Verifying Infectious Disease Data

FDA Expands Ibrexafungerp Approval for Reduction of Recurrent Yeast Infection

FDA Approves First-Ever Fecal Microbiota, RBX2660, for C Difficile Recurrence

Type I Interferon Response Linked to Resistance to HCV Infection

Trial Tests Methods to Increase COVID-19 Vaccine Response in Kidney Transplant Recipients